Trial set to begin in Boston over pregnancy drug
At first, the Melnick sisters thought it was just a cruel coincidence that two of them were diagnosed with breast cancer.
Medications
Jan 03, 2013 |
not rated yet |
0
France at odds with European medicines agency over Pill (Update)
France insisted Friday on restricting the prescription of newer-generation birth control pills even as Europe's medicines watchdog declared there was no evidence to back a health warning.
Medications
Jan 03, 2013 |
5 / 5 (1) |
1
Fulyzaq approved for ART-related diarrhea in HIV/AIDS
(HealthDay)—The first medication to treat diarrhea in people with HIV/AIDS who take antiretroviral drugs has been approved by the U.S. Food and Drug Administration.
Medications
Jan 03, 2013 |
not rated yet |
0
Drug trials in India 'causing havoc to human life'
India's Supreme Court said Thursday that unregulated clinical trials of new drugs were causing "havoc" in the country as it ordered the health ministry to monitor any new applications for tests.
Medications
Jan 03, 2013 |
5 / 5 (1) |
0
Study shows naloxone kits cost-effective in preventing overdose deaths
(Medical Xpress)—Giving heroin users kits with the overdose antidote naloxone is a cost-effective way to prevent overdose deaths and save lives, according to a study released this week in The Annals of ...
Medications
Jan 02, 2013 |
not rated yet |
0
|
Differences in generic pill characteristics may lead to interruptions in essential medication use
Generic medications currently account for over 70 percent of prescriptions dispensed. However, while generic drugs are clinically bioequivalent to the brand-name version, they often differ in their physical characteristics, ...
Medications
Dec 31, 2012 |
3 / 5 (5) |
1
|
FDA approves first new tuberculosis in 40 years
The Food and Drug Administration says it has approved a Johnson & Johnson tuberculosis drug that is the first new medicine to fight the deadly infection in more than four decades.
Medications
Dec 31, 2012 |
not rated yet |
1
FDA clears anticlotting drug Eliquis
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...
Medications
Dec 28, 2012 |
not rated yet |
0
FDA approves juxtapid for rare cholesterol disorder
(HealthDay)—The U.S. Food and Drug Administration has approved the orphan drug Juxtapid (lomitapide) for patients with homozygous familial hypercholesterolemia (HoFH), for use in combination with a low-fat ...
Medications
Dec 27, 2012 |
not rated yet |
0
Bristol-Myers, Pfizer's Eliquis approved in Japan
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications
Dec 26, 2012 |
not rated yet |
0
FDA warns doctors of counterfeit Botox
Federal regulators have warned more than 350 medical practices that Botox they may have received from a Canadian supplier is unapproved and could be counterfeit or unsafe.
Medications
Dec 24, 2012 |
not rated yet |
1
FDA expands tamiflu use to treat babies under one year old
(HealthDay)—Tamiflu (oseltamivir) can now be given to children as young as 2 weeks old under an expanded approval announced Friday by the U.S. Food and Drug Administration.
Medications
Dec 22, 2012 |
not rated yet |
2
Varizig approved to reduce chickenpox symptoms
(HealthDay)—Varizig (varicella zoster immune globulin) has been approved by the U.S. Food and Drug Administration to minimize chickenpox symptoms when administered within four days of exposure to the virus ...
Medications
Dec 22, 2012 |
not rated yet |
0
Gattex approved for short bowel syndrome
(HealthDay)—Gattex (teduglutide) has been approved by the U.S. Food and Drug Administration to treat nutritional problems caused by short bowel syndrome.
Medications
Dec 22, 2012 |
1 / 5 (1) |
1
High court asked to block morning-after pill rule
(AP)—Hobby Lobby Stores is asking the U.S. Supreme Court to block part of the federal health care law that requires it to provide insurance coverage for the morning-after pill and similar emergency contraception pills.
Medications
Dec 21, 2012 |
not rated yet |
1
